(Q54995793)

English

YUSAC2

cell line

YUSAC-2
YUSAC 2
YUSAC

In more languages

Statements

1 reference

Cellosaurus release 44

31 January 2023

cancer cell line

1 reference

Cellosaurus release 44

31 January 2023

described by source

Aberrant retention of tyrosinase in the endoplasmic reticulum mediates accelerated degradation of the enzyme and contributes to the dedifferentiated phenotype of amelanotic melanoma cells

1 reference

Cellosaurus release 44

31 January 2023

PLX4032, a selective BRAF(V600E) kinase inhibitor, activates the ERK pathway and enhances cell migration and proliferation of BRAF melanoma cells

1 reference

Cellosaurus release 44

31 January 2023

Detecting copy number status and uncovering subclonal markers in heterogeneous tumor biopsies

1 reference

Cellosaurus release 44

31 January 2023

Integrated analysis of tumor samples sheds light on tumor heterogeneity

1 reference

Cellosaurus release 44

31 January 2023

established from medical condition

1 reference

Cellosaurus release 44

31 January 2023

derived from organism type

1 reference

Cellosaurus release 44

31 January 2023

Identifiers

1 reference

Cellosaurus release 44

31 January 2023

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54995793&oldid=1861801753"